PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Barbiturates”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 775 records · Page 43Linked to original sources

Genotype-treatment interaction in response of mice to early barbiturate administration.

Results of this investigation show a differential effect of early barbiturate administration on behaviors of mice of two inbred strains in the open field and in the barrier cage. Pups of the inbred strains DBA/l and C57BL/10 were fostered by HS/Ibg dams and were given a daily injection of 50 mg/kg sodium phenobarbital on postnatal days 2-21 (treated groups); control pups received vehicle injections. At 28 and 30 days the animals were tested in an open field and in a barrier cage. The DBA/l mice responded differently from C57BL/10 to early barbiturate treatment. Treated DBA/l mice showed a marked reduction from control levels in open-field locomotion and grooming but not in defecation. In the barrier test, there were reductions in jumping, peeking and grooming and increase in defecation. The differences between controls and treated in the C57BL/10 strain were small except for barrier jumping and peeking. It is suggested that genotype (strain) - environment (drug) interaction exists for the effect of early phenobarbital administration on behavior: DBA/l was sharply affected by the drug, while the behavior of C57BL/10 was little altered by neonatal phenobarbital administration.

Animals↗

The role of angiotensin in the canine renal vascular response to barbiturate anesthesia.

The influence of barbiturate anesthesia on renal blood flow was assessed by the xenon washout method in trained dogs with catheters chronically implanted in the renal artery. Anesthesia induced with either thiopental sodium or pentobarbital sodium resulted in a striking reduction in renal blood flow (4.1 +/- 0.1 vs. 2.6 +/- 0.2 ml/g per min; P less than 0.001) without a change in arterial pressure. The reduction in blood flow was prevented by a high salt intake and partially reversed by agents which interrupt the renin-angiotensin system (BPF 9a; 1-Sar,8-Ala-angiotensin II; propranolol) but not by alpha-adrenergic blocking agents (phentolamine and phenoxybenzamine). Anesthesia blunted the renal vascular response to angiotensin II (P less than 0.0005) whereas responsiveness to norepinephrine was increased (P less than 0.05). We conclude that barbiturate anesthesia induces a major, angiotensin-mediated renal vascular response which must be considered in the interpretation of experiments performed under these conditions.

Anesthesia, Intravenous↗

Therapeutic window of CA1 neuronal damage defined by an ultrashort-acting barbiturate after brain ischemia in gerbils.

Previous therapeutic studies on the prevention of selective vulnerability of neurons in the hippocampus have suggested that the critical period for induction of delayed neuronal injury occurs early during recirculation. To determine the onset and duration of this period, an ultrashort-acting barbiturate (methohexital) was infused into the left carotid artery of 47 gerbils after various times of recirculation following 10 minutes of bilateral forebrain ischemia. Neuronal density in the left CA1 sector was determined 7 days later by counting the number of surviving neurons per millimeter of pyramidal cell layer. In 16 saline-treated gerbils, less than 10% of the CA1 neurons survived the 10 minutes of ischemia. Postischemic carotid infusion of methohexital improved neuronal survival, the degree of improvement depending on the timing and duration of the methohexital infusion. When carried out during the initial 40 minutes of recirculation, methohexital infusion for 10 minutes increased the number of surviving neurons to approximately 60% of that in five sham-operated control gerbils. This increase was significant for infusions carried out between the 10th and 20th minutes (n = 6, p less than 0.05) and between the 30th and 40th minutes (n = 6, p less than 0.05) of recirculation. Methohexital infusion for 20 minutes increased neuronal survival to 95% and 73% of that in the controls when carried out between the 0th and 20th minutes (n = 5, p less than 0.005) and between the 20th and 40th minutes (n = 5, p less than 0.005) of recirculation, respectively. Protection was nonsignificant for 10- or 20-minute methohexital infusions carried out after the 40th minute of recirculation. Our results demonstrate that the pathologic processes leading to delayed neuronal injury in the CA1 sector are induced during the initial 40 minutes of recirculation and that barbiturates are able to reverse these processes only if given during this period.

Animals↗

Barbiturates reduce human cerebral glucose metabolism.

We studied the effect of barbiturates on local cerebral glucose metabolism by performing positron emission scans before and after withdrawal of phenobarbital or primidone. The postwithdrawal scan showed a significant increase (mean, 37%) in seven of eight cortical regions tested. Patients who had serial scans without a drug change showed a nonsignificant tendency for metabolic rates to go down on the second scan (mean decrease, 7%). Addition or deletion of a single drug other than barbiturate did not change metabolic rates on repeat scans. The depression in cerebral glucose metabolic rate due to phenobarbital, if confirmed, may have bearing on the adverse neuropsychological effects of the drug.

Adult↗

[Clinical evaluation of the therapeutic value of barbexaclone including determination of plasma levels of the barbiturate].

The results of the use of barbexaclone (ciclo-hexil-aminopropan) in association with fenil-etil-barbiturate, as a single anticonvulsant drug in a clinical and therapeutic trial are reported. Seventy patients, 36 women and 34 men, 52 children and 18 adults, all of them with two or more epileptic grand-mal seizures at the beginning of treatment, were selected. In 53 patients a complete 18 months follow-up observation was performed. In this group of patients, 96% of them were free of seizures during the observation time. In 20 patients the barbiturate plasma concentration was measured. For these patients, the effectiveness of the treatment was up to 89%, in terms of complete control of convulsive crises. The measurements of the plasma level of anticonvulsants has shown to be most useful and a safe therapeutic guide in the treatment of epilepsies.

Adolescent↗

Severe acute encephalitis--improved outcome after barbiturate treatment?

Six cases of severe encephalitis due to measles, varicellae, mononucleosis, influenza, rubella and pertussis were treated with high doses of barbiturates in combination with steroids and artificial hyperventilation. Four of the patients also received antiviral therapy. They all survived without neurological sequelae. The use of barbiturates in high doses may be of importance for an improved outcome in patients with severe encephalitis.

Acyclovir↗

Synergistic inhibition by benzodiazepine and barbiturate drugs of the clock control of ovulation in hamsters.

A surge of pituitary luteinizing hormone (LH) into the bloodstream occurs in hamsters every 4 days between 1:30 p.m. and 3 p.m. in response to a signal from a biological clock. This surge initiates behavioral estrus approximately 2 h later and ovulation approximately 12 h later. Phenobarbital at a dose > or = 100 mg/kg consistently blocks LH release. Barbiturate and benzodiazepine drugs have separate binding sites in the GABAA receptor/chloride channel complex. Binding of either drug increases GABA-mediated chloride conductance, which suppresses the postsynaptic neuron. Barbiturate binding also increases benzodiazepine binding. This suggested that these drugs might synergize to inhibit LH release. A combination of triazolam and phenobarbital at doses of 10 mg/kg injected s.c. at 1:30 p.m. inhibited ovulation and extended the 4-day vaginal cycle in all treated hamsters. Either drug dose injected alone at 1:30 p.m., or the combination at 3 p.m., was completely ineffective. Bicuculline prevented inhibition by the combination at 1:30 p.m. The clock signal for LH release may act by antagonizing GABA transmission, which may be chronically inhibiting LH release. The combination delimited a 75-min period (1:30-2:45 p.m.) within which the clock signal for LH release occurred in all individuals (ET50 = 2:08 p.m.). This period appears to arise from individuals with different but constant clock settings rather than from a 75-min variation in the clock setting of the individual.

Animals↗

New biosynthetic anthracyclines related to barminomycins incorporating barbiturates in their moiety.

Three new anthracyclines, FCE 21424 (2), FCE 24366 (3) and FCE 24367 (4), were isolated from culture broths of Streptomyces peucetius and its mutant strains after addition of sodium barbiturates during the fermentation. Structural assignment, achieved through spectroscopic and degradative studies, that the new anthracyclines had a common barminomycin-like structure incorporating different barbiturate moieties. The new anthracyclines were found to display outstanding cytotoxicity and remarkable potency "in vivo" against P388 ascitic leukemia.

Animals↗

Barbiturate-mediated regulation of expression of the cytochrome P450BM-3 gene of Bacillus megaterium by Bm3R1 protein.

In a previous publication (Wen, L.-P., Ruettinger, R. T., and Fulco, A.J. (1989) J. Biol. Chem. 264, 10996-11003), we reported that about 1 kilobase of 5' flanking sequence was required for barbiturate-inducible expression of the cytochrome P450BM-3 gene in Bacillus megaterium. We have now found, by analysis of various deletion and frameshift derivatives of this region, that an open reading frame immediately upstream of the B. megaterium cytochrome P450BM-3 structural gene encodes a protein, designated Bm3R1, which negatively controls the expression of the P450BM-3 gene at the transcriptional level. A helix-turn-helix DNA binding motif was found near the N-terminal portion of Bm3R1 protein. The 5' terminus of the bm3R1 transcript generated in vivo was determined by nuclease S1 mapping and primer extension analysis to be 44 base pairs upstream of the translation initiation sequence GTG of bm3R1. A putative promoter sequence with a high degree of similarity to the -35 and -10 consensus sequence recognized by the Bacillus subtilis sigma-43 factor was located at an appropriate distance from the transcription start site. A B. megaterium mutant which highly constitutively produced P450BM-3 protein was isolated and complementation of this cytochrome P450BM-3-constitutive mutant by a DNA fragment containing the wild-type bm3R1 gene indicated that the mutation in this locus was trans-dominant. Sequence analysis of the bm3R1 gene and its upstream region from this mutant, after amplification by the polymerase chain reaction, identified a single base change that resulted in a glycine to glutamate substitution in the beta-turn region of the DNA binding motif. By placing the bm3R1 gene under the control of a tac promoter and changing the translation initiation sequence from GTG to ATG, we succeeded in overproducing the Bm3R1 protein in Escherichia coli. A 20-bp perfect palindromic putative operator site, located between the presumed promoter sequences and the bm3R1 structural gene, was defined both by in vivo titration of Bm3R1 repressor and by gel mobility shift assays using the cell-free extracts containing the overproduced wild-type or mutant Bm3R1 protein. The barbiturate effect in mediating the induction of cytochrome P450BM-3 appears to be indirect but probably involves, in part, the release of inhibition by Bm3R1 repressor protein by interfering with its binding to the palindromic putative operator sequence and perhaps to other sites on the regulatory region of the gene encoding cytochrome P450BM-3.

Amino Acid Sequence↗

[Effect of continuous barbiturate treatment on the blood flow of the mean cerebral artery in severe brain injured patients. A transcranial Doppler study].

Blood flow velocity (BFV) of the MCA has been studied by TCD of 15 patients with non operated serious cranial trauma, treated with continuous barbiturate therapy. Without hemodynamic and ventilatory modifications (PaCO2), average BFV were lowered during the course of treatment and were raised significantly when it was stopped. This study poses the question of the indication and the methods of barbiturate treatment during serious cranial trauma.

Adult↗

Ultraviolet spectrophotometry of theophylline in plasma in the presence of barbiturates.

Ultraviolet spectrophotometry is widely used for the analysis of theophylline in blood, for purposes of monitoring therapy, and for pharmacokinetic studies. Phenobarbital, a component of common oral theophylline preparations, interferes with assays now in use. The modification of the method of Schack and Waxler [J. Pharmacol. Exp. Ther. 97, 283 (1949)] presented in this paper eliminates barbiturate interference. After solvent extraction and back extraction into NaOH, the pH of the alkaline solution is adjusted from pH 13 to 10 before spectrophotometric measurement. This shifts the barbiturate absorption maximum from 255 to 240 nm, permitting accurate analysis of theophylline, the spectrum of which is unaffected by the pH change.

Humans↗

Influence of barbiturate anesthetic induction on circulatory responses to morphine.

Circulatory responses to morphine (1 mg/kg, 10 mg/min) following a barbiturate anesthetic induction (thiamylal 4 mg/kg) were determined in 7 patients with coronary artery disease. Compared with awake measurements, the mean arterial pressure and cardiac index were decreased 16 and 42 percent, respectively (p less than 0.05) and systemic vascular resistance increased 35% (p less than 0.05) at the end of morphine infusion. The same dose of morphine, but without prior barbiturate, has been previously reported not to significantly alter these measurements. Therefore, the assumption that morphine is associated with minimal circulatory changes may be invalidated by the prior administration of thiamylal.

Adjuvants, Anesthesia↗

Cloning of the gene encoding a catalytically self-sufficient cytochrome P-450 fatty acid monooxygenase induced by barbiturates in Bacillus megaterium and its functional expression and regulation in heterologous (Escherichia coli) and homologous (Bacillus megaterium) hosts.

In a previous publication (Narhi, L. O., and Fulco, A. J. (1986) J. Biol. Chem. 261, 7160-7169) we described the characterization of a 119,000-dalton P-450 cytochrome that is strongly induced by barbiturates in Bacillus megaterium. In the presence of NADPH and O2, this single polypeptide can catalyze the hydroxylation of long-chain fatty acids without the aid of any other protein. The gene encoding this unique monooxygenase (cytochrome P-450BM-3) has now been cloned by an immunochemical screening technique. The Escherichia coli clone harboring the recombinant plasmid produces a 119,000-dalton protein that appears to be electrophoretically and immunochemically identical to the B. megaterium enzyme and contains the same N-terminal amino acid sequence. The recombinant DNA product also exhibits the characteristic cytochrome P-450 spectrum and is fully functional as a fatty acid monooxygenase. In E. coli, the synthesis of P-450BM-3 is directed by its own promoter included in the DNA insert and proceeds constitutively at a very high rate but is not stimulated by pentobarbital. However, when the cloned P-450BM-3 gene, either intact or in a truncated form, is introduced back into B. megaterium via an E. coli/Bacillus subtilis shuttle vector, its expression is constitutively repressed but is induced by pentobarbital. This finding demonstrates that the regulatory region of the P-450BM-3 gene that responds to barbiturates is included in the cloned DNA. The evidence also indicates that pentobarbital cannot directly act on the gene to cause induction but presumably interacts with another component such as a repressor molecule that is present in B. megaterium but is absent in the E. coli clone.

Bacillus megaterium↗

Experience with barbiturate therapy for cerebral protection during carotid endarterectomy.

Carotid endarterectomy was performed 28 times in 27 patients. All but one patient had symptomatic carotid artery disease, 59% had bilateral disease and 59% had associated intracranial disease. Barbiturate therapy was used as a means of cerebral protection during carotid artery cross-clamping. Neurological deficit occurred in two patients, being permanent in one patient (3.5%); both patients had bilateral carotid and intracranial disease and both had carotid stump pressures greater than 55 mmHg. No morbidity could be attributed to barbiturate usage.

Adult↗

Hazards of high dose barbiturate therapy in head-injury patients.

Despite of controversial findings, High-Dose-Barbiturate Therapy is advocated by many authors for treatment of postischemic/anoxic encephalopathy and head trauma with elevated intracranial pressure. The adverse effects to thiopentone are analyzed in a retrospective study including 30 patients treated by high-dose thiopentone for raised intracranial pressure after severe head injury. The pathophysiology and occurrence of clinical complications in many systems of the organism are illustrated. The specific prevention measures and the extended monitoring of barbiturate-treated patients are described. Considering the high incidence of clinical complications the indication for HDBT has to be reevaluated.

Cardiovascular System↗

[Reaction of the body to the effect of barbiturates and the activity of monoaminergic processes in the brain].

The adaptive reaction to barbiturates was studied in the presence of a seasonally varying monoamine content and metabolism in the brain. The effectiveness of amobarbital and monoamine content in mouse brain were determined monthly during 5 years. It has been demonstrated that both adaptive reactivity of mice and monoamine content in the brain show a similar seasonal periodicity. The conclusion is made that adaptive reactivity determining the depth and duration of amobarbital anesthesia correlates mainly with the activity of serotoninergic processes. Activation of adaptive reactions caused by repeated administration of the barbiturate correlates with the activity of dopaminergic processes.

Adaptation, Physiological↗

[Age and the effects of barbiturates on rat liver microsome oxidative enzymes].

It was shown in experiments on male white rats aged 1, 3, 6 and 25 months that the content of cytochrome P 450 and aminopyrindemethylase activity of liver microsomes decrease in old animals as compared with younger ones. No age-associated differences were revealed in old rats as compared with adult ones as regards all the parameters studied. During administration of barbiturates the induction of aminopyrindemethylase, the content of cytochromes P 450 and b5, microsomal protein and liver weight is pronounced to a far greater extent in one-month-old animals, it being decreased with age. Changes in the duration of narcotic-induced sleep (administration of barbiturates) set in earlier and are more pronounced in young animals than in adult or old ones.

Age Factors↗

Acute and chronic effects of barbiturates on depolarization-induced calcium influx into synaptosomes from rat brain regions.

Male Sprague-Dawley rats (250--300 g) were randomly divided into three experimental groups: control, acute (received a single dose of 60 mg/kg of phenobarbital i.p.) and tolerant (received dietary phenobarbital, 2.5 mg/kg of milled Purina Lab Chow, for 13 days). Cerebral cortex (CT), cerebellum (CB), brain stem (BS), striatum (ST), hypothalamus (HT), and mid-brain (MB) were isolated, and the inhibitory effects of barbiturates on KCl-induced 45Ca++ influx into synaptosomes from each of these brain regions isolated from each experimental group were examined. KCl-induced 45Ca++ influx into CT, CB and BS synaptosomes from control animals was significantly depressed (39, 73 and 77% respectively) by an in vitro pentobarbital (0.3 mM) challenge. No significant depression of 45Ca++ influx was produced by pentobarbital in control synaptosomes isolated from ST, HT or MB. KCl-induced 45Ca++ influx into synaptosomes from tolerant rats was not significantly depressed by the in vitro pentobarbital challenge in any brain area. The results suggest that 45Ca++ influx into synaptosomes from CT, CB and BS is more susceptible than ST, HT and MB to inhibition by barbiturates. In addition, chronic administration of phenobarbital resulted in the adaptation of CT, CB and BS synaptosomes to the inhibitory effects of in vitro pentobarbital. This adaptation occurred in the same time frame as did the development of behavioral tolerance.

Animals↗